We serve Chemical Name:2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol CAS:523-67-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol
CAS.NO:523-67-1
Synonyms:1-Azo-2-hydroxy-3-(2,4-dimethylcarboxyanilido)naphthalene-1-(2-hydroxybenzene);2-[2-HYDROXY-3-(2,4-XYLYLCARBAMOYL)-1-NAPHTHYLAZO]PHENOL;Xylidyl Blue II;MFCD00014309;Xylylazo Violet II;EINECS 208-347-1
Molecular Formula:C25H21N3O3
Molecular Weight:411.45300
HS Code:2927000090
Physical and Chemical Properties:
Melting point:247 °C
Boiling point:N/A
Density:1.26g/cm3
Index of Refraction:1.652
PSA:94.28000
Exact Mass:411.15800
LogP:6.60850
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Azo-2-hydroxy-3-(2,4-dimethylcarboxyanilido)naphthalene-1-(2-hydroxybenzene) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 208-347-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Azo-2-hydroxy-3-(2,4-dimethylcarboxyanilido)naphthalene-1-(2-hydroxybenzene) Use and application,MFCD00014309 technical grade,usp/ep/jp grade.
Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol manufacturer The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. 2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol supplier In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol vendor According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. 2-[2-Hydroxy-3-(2,4-xylylcarbamoyl)-1-naphthylazo]phenol factory According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.